Increased Expression of Herpes Virus-Encoded hsv1-miR-H18 and hsv2-miR-H9-5p in Cancer-Containing Prostate Tissue Compared to That in Benign Prostate Hyperplasia Tissue

Previously, we reported the presence of virus-encoded microRNAs (miRNAs) in the urine of prostate cancer (CaP) patients. In this study, we investigated the expression of two herpes virus-encoded miRNAs in prostate tissue. A total of 175 tissue samples from noncancerous benign prostatic hyperplasia (...

Full description

Saved in:
Bibliographic Details
Published inInternational neurourology journal Vol. 20; no. 2; pp. 122 - 130
Main Authors Yun, Seok Joong, Jeong, Pildu, Kang, Ho Won, Shinn, Helen Ki, Kim, Ye-Hwan, Yan, Chunri, Choi, Young-Ki, Kim, Dongho, Ryu, Dong Hee, Ha, Yun-Sok, Kim, Tae-Hwan, Kwon, Tae Gyun, Kim, Jung Min, Suh, Sang Heon, Kim, Seon-Kyu, Kim, Seon-Young, Kim, Sang Tae, Kim, Won Tae, Lee, Ok-Jun, Moon, Sung-Kwon, Kim, Nam-Hyung, Kim, Isaac Yi, Kim, Jayoung, Cha, Hee-Jae, Choi, Yung-Hyun, Cha, Eun-Jong, Kim, Wun-Jae
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Continence Society 01.06.2016
대한배뇨장애요실금학회
Subjects
Online AccessGet full text
ISSN2093-6931
2093-4777
2093-6931
DOI10.5213/inj.1632552.276

Cover

Abstract Previously, we reported the presence of virus-encoded microRNAs (miRNAs) in the urine of prostate cancer (CaP) patients. In this study, we investigated the expression of two herpes virus-encoded miRNAs in prostate tissue. A total of 175 tissue samples from noncancerous benign prostatic hyperplasia (BPH), 248 tissue samples from patients with CaP and BPH, and 50 samples from noncancerous surrounding tissues from these same patients were analyzed for the expression of two herpes virus-encoded miRNAs by real-time polymerase chain reaction (PCR) and immunocytochemistry using nanoparticles as molecular beacons. Real-time reverse transcription-PCR results revealed significantly higher expression of hsv1-miR-H18 and hsv2-miRH9- 5p in surrounding noncancerous and CaP tissues than that in BPH tissue (each comparison, P<0.001). Of note, these miRNA were expressed equivalently in the CaP tissues and surrounding noncancerous tissues. Moreover, immunocytochemistry clearly demonstrated a significant enrichment of both hsv1-miR-H18 and hsv2-miR-H9 beacon-labeled cells in CaP and surrounding noncancerous tissue compared to that in BPH tissue (each comparison, P<0.05 for hsv1-miR-H18 and hsv2- miR-H9). These results suggest that increased expression of hsv1-miR-H18 and hsv2-miR-H95p might be associated with tumorigenesis in the prostate. Further studies will be required to elucidate the role of these miRNAs with respect to CaP and herpes viral infections.
AbstractList Purpose: Previously, we reported the presence of virus-encoded microRNAs (miRNAs) in the urine of prostate cancer (CaP) patients. In this study, we investigated the expression of two herpes virus-encoded miRNAs in prostate tissue. Methods: A total of 175 tissue samples from noncancerous benign prostatic hyperplasia (BPH), 248 tissue samples from patients with CaP and BPH, and 50 samples from noncancerous surrounding tissues from these same patients were analyzed for the expression of two herpes virus-encoded miRNAs by real-time polymerase chain reaction (PCR) and immunocytochemistry using nanoparticles as molecular beacons. Results: Real-time reverse transcription-PCR results revealed significantly higher expression of hsv1-miR-H18 and hsv2-miRH9- 5p in surrounding noncancerous and CaP tissues than that in BPH tissue (each comparison, P<0.001). Of note, these miRNA were expressed equivalently in the CaP tissues and surrounding noncancerous tissues. Moreover, immunocytochemistry clearly demonstrated a significant enrichment of both hsv1-miR-H18 and hsv2-miR-H9 beacon-labeled cells in CaP and surrounding noncancerous tissue compared to that in BPH tissue (each comparison, P<0.05 for hsv1-miR-H18 and hsv2- miR-H9). Conclusions: These results suggest that increased expression of hsv1-miR-H18 and hsv2-miR-H95p might be associated with tumorigenesis in the prostate. Further studies will be required to elucidate the role of these miRNAs with respect to CaP and herpes viral infections.
Purpose: Previously, we reported the presence of virus-encoded microRNAs (miRNAs) in the urine of prostate cancer (CaP) patients. In this study, we investigated the expression of two herpes virus-encoded miRNAs in prostate tissue. Methods: A total of 175 tissue samples from noncancerous benign prostatic hyperplasia (BPH), 248 tissue samples from patients with CaP and BPH, and 50 samples from noncancerous surrounding tissues from these same patients were analyzed for the expression of two herpes virus-encoded miRNAs by real-time polymerase chain reaction (PCR) and immunocytochemistry using nanoparticles as molecular beacons. Results: Real-time reverse transcription-PCR results revealed significantly higher expression of hsv1-miR-H18 and hsv2-miRH9- 5p in surrounding noncancerous and CaP tissues than that in BPH tissue (each comparison, P<0.001). Of note, these miRNA were expressed equivalently in the CaP tissues and surrounding noncancerous tissues. Moreover, immunocytochemistry clearly demonstrated a significant enrichment of both hsv1-miR-H18 and hsv2-miR-H9 beacon-labeled cells in CaP and surrounding noncancerous tissue compared to that in BPH tissue (each comparison, P<0.05 for hsv1-miR-H18 and hsv2- miR-H9). Conclusions: These results suggest that increased expression of hsv1-miR-H18 and hsv2-miR-H95p might be associated with tumorigenesis in the prostate. Further studies will be required to elucidate the role of these miRNAs with respect to CaP and herpes viral infections. KCI Citation Count: 12
Previously, we reported the presence of virus-encoded microRNAs (miRNAs) in the urine of prostate cancer (CaP) patients. In this study, we investigated the expression of two herpes virus-encoded miRNAs in prostate tissue.PURPOSEPreviously, we reported the presence of virus-encoded microRNAs (miRNAs) in the urine of prostate cancer (CaP) patients. In this study, we investigated the expression of two herpes virus-encoded miRNAs in prostate tissue.A total of 175 tissue samples from noncancerous benign prostatic hyperplasia (BPH), 248 tissue samples from patients with CaP and BPH, and 50 samples from noncancerous surrounding tissues from these same patients were analyzed for the expression of two herpes virus-encoded miRNAs by real-time polymerase chain reaction (PCR) and immunocytochemistry using nanoparticles as molecular beacons.METHODSA total of 175 tissue samples from noncancerous benign prostatic hyperplasia (BPH), 248 tissue samples from patients with CaP and BPH, and 50 samples from noncancerous surrounding tissues from these same patients were analyzed for the expression of two herpes virus-encoded miRNAs by real-time polymerase chain reaction (PCR) and immunocytochemistry using nanoparticles as molecular beacons.Real-time reverse transcription-PCR results revealed significantly higher expression of hsv1-miR-H18 and hsv2-miRH9- 5p in surrounding noncancerous and CaP tissues than that in BPH tissue (each comparison, P<0.001). Of note, these miRNA were expressed equivalently in the CaP tissues and surrounding noncancerous tissues. Moreover, immunocytochemistry clearly demonstrated a significant enrichment of both hsv1-miR-H18 and hsv2-miR-H9 beacon-labeled cells in CaP and surrounding noncancerous tissue compared to that in BPH tissue (each comparison, P<0.05 for hsv1-miR-H18 and hsv2- miR-H9).RESULTSReal-time reverse transcription-PCR results revealed significantly higher expression of hsv1-miR-H18 and hsv2-miRH9- 5p in surrounding noncancerous and CaP tissues than that in BPH tissue (each comparison, P<0.001). Of note, these miRNA were expressed equivalently in the CaP tissues and surrounding noncancerous tissues. Moreover, immunocytochemistry clearly demonstrated a significant enrichment of both hsv1-miR-H18 and hsv2-miR-H9 beacon-labeled cells in CaP and surrounding noncancerous tissue compared to that in BPH tissue (each comparison, P<0.05 for hsv1-miR-H18 and hsv2- miR-H9).These results suggest that increased expression of hsv1-miR-H18 and hsv2-miR-H95p might be associated with tumorigenesis in the prostate. Further studies will be required to elucidate the role of these miRNAs with respect to CaP and herpes viral infections.CONCLUSIONSThese results suggest that increased expression of hsv1-miR-H18 and hsv2-miR-H95p might be associated with tumorigenesis in the prostate. Further studies will be required to elucidate the role of these miRNAs with respect to CaP and herpes viral infections.
Previously, we reported the presence of virus-encoded microRNAs (miRNAs) in the urine of prostate cancer (CaP) patients. In this study, we investigated the expression of two herpes virus-encoded miRNAs in prostate tissue. A total of 175 tissue samples from noncancerous benign prostatic hyperplasia (BPH), 248 tissue samples from patients with CaP and BPH, and 50 samples from noncancerous surrounding tissues from these same patients were analyzed for the expression of two herpes virus-encoded miRNAs by real-time polymerase chain reaction (PCR) and immunocytochemistry using nanoparticles as molecular beacons. Real-time reverse transcription-PCR results revealed significantly higher expression of hsv1-miR-H18 and hsv2-miRH9- 5p in surrounding noncancerous and CaP tissues than that in BPH tissue (each comparison, P<0.001). Of note, these miRNA were expressed equivalently in the CaP tissues and surrounding noncancerous tissues. Moreover, immunocytochemistry clearly demonstrated a significant enrichment of both hsv1-miR-H18 and hsv2-miR-H9 beacon-labeled cells in CaP and surrounding noncancerous tissue compared to that in BPH tissue (each comparison, P<0.05 for hsv1-miR-H18 and hsv2- miR-H9). These results suggest that increased expression of hsv1-miR-H18 and hsv2-miR-H95p might be associated with tumorigenesis in the prostate. Further studies will be required to elucidate the role of these miRNAs with respect to CaP and herpes viral infections.
Author Kim, Wun-Jae
Ha, Yun-Sok
Kim, Nam-Hyung
Kim, Won Tae
Kwon, Tae Gyun
Choi, Young-Ki
Lee, Ok-Jun
Kim, Jung Min
Kim, Tae-Hwan
Kim, Dongho
Kim, Sang Tae
Cha, Eun-Jong
Kim, Ye-Hwan
Choi, Yung-Hyun
Kim, Isaac Yi
Yun, Seok Joong
Kim, Jayoung
Kang, Ho Won
Jeong, Pildu
Suh, Sang Heon
Yan, Chunri
Kim, Seon-Young
Shinn, Helen Ki
Ryu, Dong Hee
Moon, Sung-Kwon
Cha, Hee-Jae
Kim, Seon-Kyu
Author_xml – sequence: 1
  givenname: Seok Joong
  surname: Yun
  fullname: Yun, Seok Joong
– sequence: 2
  givenname: Pildu
  surname: Jeong
  fullname: Jeong, Pildu
– sequence: 3
  givenname: Ho Won
  surname: Kang
  fullname: Kang, Ho Won
– sequence: 4
  givenname: Helen Ki
  surname: Shinn
  fullname: Shinn, Helen Ki
– sequence: 5
  givenname: Ye-Hwan
  surname: Kim
  fullname: Kim, Ye-Hwan
– sequence: 6
  givenname: Chunri
  surname: Yan
  fullname: Yan, Chunri
– sequence: 7
  givenname: Young-Ki
  surname: Choi
  fullname: Choi, Young-Ki
– sequence: 8
  givenname: Dongho
  surname: Kim
  fullname: Kim, Dongho
– sequence: 9
  givenname: Dong Hee
  surname: Ryu
  fullname: Ryu, Dong Hee
– sequence: 10
  givenname: Yun-Sok
  surname: Ha
  fullname: Ha, Yun-Sok
– sequence: 11
  givenname: Tae-Hwan
  surname: Kim
  fullname: Kim, Tae-Hwan
– sequence: 12
  givenname: Tae Gyun
  surname: Kwon
  fullname: Kwon, Tae Gyun
– sequence: 13
  givenname: Jung Min
  surname: Kim
  fullname: Kim, Jung Min
– sequence: 14
  givenname: Sang Heon
  surname: Suh
  fullname: Suh, Sang Heon
– sequence: 15
  givenname: Seon-Kyu
  surname: Kim
  fullname: Kim, Seon-Kyu
– sequence: 16
  givenname: Seon-Young
  surname: Kim
  fullname: Kim, Seon-Young
– sequence: 17
  givenname: Sang Tae
  surname: Kim
  fullname: Kim, Sang Tae
– sequence: 18
  givenname: Won Tae
  surname: Kim
  fullname: Kim, Won Tae
– sequence: 19
  givenname: Ok-Jun
  surname: Lee
  fullname: Lee, Ok-Jun
– sequence: 20
  givenname: Sung-Kwon
  surname: Moon
  fullname: Moon, Sung-Kwon
– sequence: 21
  givenname: Nam-Hyung
  surname: Kim
  fullname: Kim, Nam-Hyung
– sequence: 22
  givenname: Isaac Yi
  surname: Kim
  fullname: Kim, Isaac Yi
– sequence: 23
  givenname: Jayoung
  surname: Kim
  fullname: Kim, Jayoung
– sequence: 24
  givenname: Hee-Jae
  surname: Cha
  fullname: Cha, Hee-Jae
– sequence: 25
  givenname: Yung-Hyun
  surname: Choi
  fullname: Choi, Yung-Hyun
– sequence: 26
  givenname: Eun-Jong
  surname: Cha
  fullname: Cha, Eun-Jong
– sequence: 27
  givenname: Wun-Jae
  surname: Kim
  fullname: Kim, Wun-Jae
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27377944$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002122042$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp1Uk1v0zAYttAQG2VnbihHOKTzZ-xckLao0EqTQFPhajmO3bpL7WCnE_tH_Ey8toMNCV9e6_XzYft9XoMTH7wB4C2CU4YRuXB-M0UVwYzhKebVC3CGYU3Kqibo5Mn-FJyntIF5Ucoh46_AKeaE85rSM_Br4XU0KpmumP0coknJBV8EW8xNHEwqvru4S-XM69BlyDrdoXLrbso5EoXy-wY-NOqSDYXzRaO8NrFsgh-V886viq8xpFGNpli6lHamaMJ2UDGrjaFYrtX4wLoy3q38X-j8fsj-vUpOHWlvwEur-mTOj3UCvn2aLZt5ef3l86K5vC41rclY1gIpYZiGHVLW1jXWrIM1JBwz1Fa2RZYzi4iGFGLBta0MJUIjKzomWkgEmYAPB10frbzVTgbl9nUV5G2UlzfLhUQQVUzwjF0csF1QGzlEt1Xxfk_YN0JcSRVHp3sjsWi1gZgoriqKjBIVsoRCJBirO9uSrPXxoDXs2q3ptPFjVP0z0ecn3q3zne5kfjauKM0C748CMfzYmTTKrUva9L3yJuySRAJiygnLsZiAd0-9_pg8xiID2AGg80BSNFZql-eSo5GtXZ8_QD4kUOYEymMCM7nKvIt_eI_S_2P8BrAZ3ac
CitedBy_id crossref_primary_10_1016_j_prnil_2021_11_003
crossref_primary_10_1016_j_exger_2021_111304
crossref_primary_10_1007_s12223_020_00780_x
crossref_primary_10_1002_rmv_2081
crossref_primary_10_1177_1756287219857271
crossref_primary_10_1128_jvi_00349_22
crossref_primary_10_1016_j_euf_2018_01_008
crossref_primary_10_4111_icu_20210493
crossref_primary_10_1016_j_jneuroim_2017_03_002
crossref_primary_10_5213_inj_1836262_131
crossref_primary_10_1186_s12610_023_00193_z
Cites_doi 10.1038/nrc2090
10.3322/caac.20073
10.1038/nprot.2006.162
10.1186/1471-2105-11-249
10.1126/science.1096781
10.3346/jkms.2009.24.6.995
10.5213/inj.2015.19.2.74
10.1002/path.2936
10.1016/j.vaccine.2008.05.064
10.1016/S1097-2765(01)00227-1
10.1016/j.canep.2014.06.002
10.1016/0090-4295(84)90118-3
10.1073/pnas.1318157111
10.1002/smll.200500360
10.1158/1055-9965.EPI-08-1167
10.1038/nmeth746
10.2217/fon.10.95
10.1158/1055-9965.EPI-07-0134
ContentType Journal Article
Copyright Copyright © 2016 Korean Continence Society 2016
Copyright_xml – notice: Copyright © 2016 Korean Continence Society 2016
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
ACYCR
DOI 10.5213/inj.1632552.276
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2093-6931
EndPage 130
ExternalDocumentID oai_kci_go_kr_ARTI_1016587
oai_doaj_org_article_28bce023a7a641ea861f34018559dfb3
PMC4932644
27377944
10_5213_inj_1632552_276
Genre Journal Article
GroupedDBID ---
5-W
53G
8JR
8XY
9ZL
AAKDD
AAYXX
ABDBF
ACUHS
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
E3Z
EBD
EF.
F5P
GROUPED_DOAJ
HYE
OK1
RPM
NPM
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c493t-981a8e5c0d1aff992c5d09037251b6fb1f75f13c040287cf6e438c1f8d58b0383
IEDL.DBID DOA
ISSN 2093-6931
2093-4777
IngestDate Tue Nov 21 21:43:34 EST 2023
Wed Aug 27 01:31:13 EDT 2025
Thu Aug 21 14:05:06 EDT 2025
Fri Jul 11 07:52:59 EDT 2025
Thu Jan 02 22:25:12 EST 2025
Tue Jul 01 00:28:41 EDT 2025
Thu Apr 24 23:06:22 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Prostate Neoplasms
Herpesviridae
MicroRNAs
Prostate Hyperplasia
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c493t-981a8e5c0d1aff992c5d09037251b6fb1f75f13c040287cf6e438c1f8d58b0383
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Geun Ho Park and Helen Ki Shinn contributed equally to this study as co-first authors.
G704-001728.2016.20.2.007
ORCID 0000-0002-1967-5281
0000-0001-6319-0217
0000-0002-1030-7730
0000-0002-4390-0952
0000-0003-4560-8880
0000-0002-1409-3311
0000-0002-1454-3124
0000-0002-4176-5187
0000-0001-6088-298X
0000-0002-8060-8926
0000-0003-3732-9814
0000-0001-7737-4746
0000-0002-8164-4427
0000-0002-5602-5376
0000-0002-1894-9869
0000-0002-8676-7119
0000-0002-6963-2685
OpenAccessLink https://doaj.org/article/28bce023a7a641ea861f34018559dfb3
PMID 27377944
PQID 1802473509
PQPubID 23479
PageCount 9
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_1016587
doaj_primary_oai_doaj_org_article_28bce023a7a641ea861f34018559dfb3
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4932644
proquest_miscellaneous_1802473509
pubmed_primary_27377944
crossref_citationtrail_10_5213_inj_1632552_276
crossref_primary_10_5213_inj_1632552_276
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-06-01
PublicationDateYYYYMMDD 2016-06-01
PublicationDate_xml – month: 06
  year: 2016
  text: 2016-06-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle International neurourology journal
PublicationTitleAlternate Int Neurourol J
PublicationYear 2016
Publisher Korean Continence Society
대한배뇨장애요실금학회
Publisher_xml – name: Korean Continence Society
– name: 대한배뇨장애요실금학회
References ref13
ref12
ref15
ref14
ref11
ref10
Ge (ref20) 2013
ref2
ref1
ref17
ref16
ref19
ref18
ref8
ref7
ref9
ref3
ref6
ref5
Sfanos (ref4) 2013
20465802 - BMC Bioinformatics. 2010 May 13;11:249
17193022 - Small. 2006 Feb;2(2):209-15
28043100 - Int Neurourol J. 2016 Dec;20(4):374
19949651 - J Korean Med Sci. 2009 Dec;24(6):995-1003
21744342 - J Pathol. 2011 Sep;225(1):19-28
15782219 - Nat Methods. 2005 Apr;2(4):269-76
26126436 - Int Neurourol J. 2015 Jun;19(2):74-84
18847553 - Vaccine. 2008 Aug 19;26 Suppl 10:K1-16
24367088 - Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):E592-600
24648964 - Biomed Rep. 2013 May;1(3):433-439
19755645 - Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2665-71
17406398 - Nat Protoc. 2006;1(3):1160-4
15118162 - Science. 2004 Apr 30;304(5671):734-6
17384581 - Nat Rev Cancer. 2007 Apr;7(4):256-69
24986642 - Cancer Epidemiol. 2014 Aug;38(4):329-38
20610543 - CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
20799875 - Future Oncol. 2010 Aug;6(8):1289-311
11336706 - Mol Cell. 2001 Apr;7(4):833-43
25110720 - Am J Clin Exp Urol. 2013 Dec 25;1(1):3-11
17684131 - Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1573-80
6209848 - Urology. 1984 Dec;24(6):623-5
References_xml – ident: ref3
  doi: 10.1038/nrc2090
– ident: ref1
  doi: 10.3322/caac.20073
– ident: ref12
  doi: 10.1038/nprot.2006.162
– ident: ref8
  doi: 10.1186/1471-2105-11-249
– ident: ref14
  doi: 10.1126/science.1096781
– start-page: 3
  volume-title: Infections and inflammation in prostate cancer
  year: 2013
  ident: ref4
– ident: ref2
  doi: 10.3346/jkms.2009.24.6.995
– ident: ref10
  doi: 10.5213/inj.2015.19.2.74
– ident: ref13
  doi: 10.1002/path.2936
– ident: ref15
  doi: 10.1016/j.vaccine.2008.05.064
– ident: ref9
  doi: 10.1016/S1097-2765(01)00227-1
– ident: ref6
  doi: 10.1016/j.canep.2014.06.002
– ident: ref17
  doi: 10.1016/0090-4295(84)90118-3
– start-page: 433
  volume-title: Herpes simplex virus type 2 or human herpesvirus 8 infection and prostate cancer risk: a meta-analysis
  year: 2013
  ident: ref20
– ident: ref5
  doi: 10.1073/pnas.1318157111
– ident: ref11
  doi: 10.1002/smll.200500360
– ident: ref18
  doi: 10.1158/1055-9965.EPI-08-1167
– ident: ref7
  doi: 10.1038/nmeth746
– ident: ref16
  doi: 10.2217/fon.10.95
– ident: ref19
  doi: 10.1158/1055-9965.EPI-07-0134
– reference: 15118162 - Science. 2004 Apr 30;304(5671):734-6
– reference: 28043100 - Int Neurourol J. 2016 Dec;20(4):374
– reference: 17406398 - Nat Protoc. 2006;1(3):1160-4
– reference: 17384581 - Nat Rev Cancer. 2007 Apr;7(4):256-69
– reference: 25110720 - Am J Clin Exp Urol. 2013 Dec 25;1(1):3-11
– reference: 26126436 - Int Neurourol J. 2015 Jun;19(2):74-84
– reference: 19949651 - J Korean Med Sci. 2009 Dec;24(6):995-1003
– reference: 24986642 - Cancer Epidemiol. 2014 Aug;38(4):329-38
– reference: 20465802 - BMC Bioinformatics. 2010 May 13;11:249
– reference: 6209848 - Urology. 1984 Dec;24(6):623-5
– reference: 11336706 - Mol Cell. 2001 Apr;7(4):833-43
– reference: 24648964 - Biomed Rep. 2013 May;1(3):433-439
– reference: 18847553 - Vaccine. 2008 Aug 19;26 Suppl 10:K1-16
– reference: 19755645 - Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2665-71
– reference: 17684131 - Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1573-80
– reference: 15782219 - Nat Methods. 2005 Apr;2(4):269-76
– reference: 21744342 - J Pathol. 2011 Sep;225(1):19-28
– reference: 17193022 - Small. 2006 Feb;2(2):209-15
– reference: 20799875 - Future Oncol. 2010 Aug;6(8):1289-311
– reference: 24367088 - Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):E592-600
– reference: 20610543 - CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
SSID ssj0000447057
Score 2.0961514
Snippet Previously, we reported the presence of virus-encoded microRNAs (miRNAs) in the urine of prostate cancer (CaP) patients. In this study, we investigated the...
Purpose: Previously, we reported the presence of virus-encoded microRNAs (miRNAs) in the urine of prostate cancer (CaP) patients. In this study, we...
SourceID nrf
doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 122
SubjectTerms Herpesviridae
MicroRNAs
Original
Prostate Hyperplasia
Prostate Neoplasms
비뇨기과학
Title Increased Expression of Herpes Virus-Encoded hsv1-miR-H18 and hsv2-miR-H9-5p in Cancer-Containing Prostate Tissue Compared to That in Benign Prostate Hyperplasia Tissue
URI https://www.ncbi.nlm.nih.gov/pubmed/27377944
https://www.proquest.com/docview/1802473509
https://pubmed.ncbi.nlm.nih.gov/PMC4932644
https://doaj.org/article/28bce023a7a641ea861f34018559dfb3
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002122042
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX International Neurourology Journal, 2016, 20(2), , pp.122-130
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQHhAXxPIMLxnEgYt348aJnSNbdVWQFiHURXuzHD-20YJbpe2Kn8TPZMbJlhaBuHCK5NiRkxnPfOOMvyHkDe6tgR_3zEnnmfAlZ8YEx0LpmkLg6vJ4OPnsYzU9Fx8uyoudUl-YE9bTA_cf7nikGuvBsRhpKsG9URUPBQQFCqCwC03i-czrfCeYSjZYCJknmk-4WTAhpex5fcBbFcdtBAtRFYCmR0cjZBvZcUmJuR8cTezCn0Dn77mTO87o9B65O6BI-q6f_SG55eN9cvts-E_-gPyAZY_Z5t7Ryfch1TXSRaBT3y39in5pu82KTSIeaHd0vrrm7Fv7mU25oiamhlHfULNySdtIx6gcHUMuq76kBP2Ex0UAqNJZEh0dD8nsdL2gs7lZ46gTH9vL-KvrFILebpkObg7DHpLz08lsPGVDTQZmRV2sWa24Ub60ueMmhLoe2dLhVo8EnNRUoeFBloEXFmwDxGI2VF4UyvKgXKmaHMLhR-QgLqJ_QmiwYKUdd0IJJ7z0tRfCFvBUaeAZdZWRoxuxaDsQlmPdjK8aAheUowY56kGOGuSYkbfbAcueq-PvXU9QzttuSLKdGkD19KB6-l-ql5HXoCX6yrZpPF4vF_qq0xCKvE-5c6WSGXl1o0QaVi7-jjHRLzYrjdx7WPg5rzPyuFeq7XwAVEqwlCIjck_d9ia8fye288QOLhCRC_H0f7zhM3IHAGLVp8Y9JwfrbuNfAAhbNy_TevsJecAttw
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+Expression+of+Herpes+Virus-Encoded+hsv1-miR-H18+and+hsv2-miR-H9-5p+in+Cancer-Containing+Prostate+Tissue+Compared+to+That+in+Benign+Prostate+Hyperplasia+Tissue&rft.jtitle=International+neurourology+journal&rft.au=Yun%2C+Seok+Joong&rft.au=Jeong%2C+Pildu&rft.au=Kang%2C+Ho+Won&rft.au=Shinn%2C+Helen+Ki&rft.date=2016-06-01&rft.pub=Korean+Continence+Society&rft.issn=2093-4777&rft.eissn=2093-6931&rft.volume=20&rft.issue=2&rft.spage=122&rft.epage=130&rft_id=info:doi/10.5213%2Finj.1632552.276&rft_id=info%3Apmid%2F27377944&rft.externalDocID=PMC4932644
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2093-6931&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2093-6931&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2093-6931&client=summon